cjc 1295 ipamorelin mechanism of action gh igf 1 release CJC-1295 (no DAC) | Modified GRF 1-29 CJC-1295 Research Guide: DAC vs

Studies have demonstrated measurable lipolytic activity in adipose tissue while confirming the absence of significant changes in blood glucose, insulin sensitivity, or IGF-1 levels, validating its utility as a targeted research tool for studying fat metabolism pathways independently of growth axis effects

The micrograms delivered are identical

107(6):771781 Endocrine and metabolic roles of insulin-like growth factor signaling in experimental models Sjgren K, Jansson JO, Isaksson OG, Ohlsson C., Minerva Endocrinologica , 2002

While this has its own set of important research applications, its a world away from the goals of a No DAC blend